Literature DB >> 17010905

The clinical application of intensity-modulated radiation therapy.

Randall K Ten Haken1, Theodore S Lawrence.   

Abstract

Intensity-modulated radiation therapy is a delivery system that, when coupled with a treatment-planning optimization system, presents the opportunity to conform the dose to the target better than 3-dimensional conformal therapy, particularly in the case of concave targets. Appropriate clinical applications of this technology to challenging patient treatment scenarios requires careful consideration of issues related to target volume-dose heterogeneity and the influence of patient setup uncertainties. These issues are reviewed and illustrated. To date, clinical reports of these treatments for prostate and head and neck cancers have the most mature data. Those results are summarized here. Future applications of this technology can be expected to take careful, considered advantage of this technology to further rearrange dose distributions across target volumes to produce an integrated overall gain in treatment objectives. However, these innovative applications need to be approached with caution, preferably in prospective clinical trials that would help determine if the hypothetical clinical benefits are in fact realizable.

Entities:  

Mesh:

Year:  2006        PMID: 17010905     DOI: 10.1016/j.semradonc.2006.04.005

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  7 in total

Review 1.  Reirradiation of Skull Base Tumors With Advanced Highly Conformal Techniques.

Authors:  Jennifer C Ho; Jack Phan
Journal:  Curr Oncol Rep       Date:  2017-10-28       Impact factor: 5.075

Review 2.  Global radiation oncology waybill.

Authors:  Victor Muñoz-Garzón; Angeles Rovirosa; Alfredo Ramos
Journal:  Rep Pract Oncol Radiother       Date:  2013-10-30

Review 3.  18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy.

Authors:  Eric C Ford; Joseph Herman; Ellen Yorke; Richard L Wahl
Journal:  J Nucl Med       Date:  2009-09-16       Impact factor: 10.057

4.  Genetics and genomics of radiotherapy toxicity: towards prediction.

Authors:  Catharine M West; Gillian C Barnett
Journal:  Genome Med       Date:  2011-08-23       Impact factor: 11.117

Review 5.  Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype.

Authors:  Gillian C Barnett; Catherine M L West; Alison M Dunning; Rebecca M Elliott; Charlotte E Coles; Paul D P Pharoah; Neil G Burnet
Journal:  Nat Rev Cancer       Date:  2009-01-16       Impact factor: 60.716

6.  Optimal planning target volume margins for elective pelvic lymphatic radiotherapy in high-risk prostate cancer patients.

Authors:  Benjamin K Hinton; John B Fiveash; Xingen Wu; Michael C Dobelbower; Robert Y Kim; Rojymon Jacob
Journal:  ISRN Oncol       Date:  2013-03-07

Review 7.  Managing an Older Adult with Cancer: Considerations for Radiation Oncologists.

Authors:  Sanders Chang; Nathan E Goldstein; Kavita V Dharmarajan
Journal:  Biomed Res Int       Date:  2017-12-13       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.